RESUMO
OBJECTIVES: Fibromyalgia (FM) is a complex syndrome whose hallmark features are chronic widespread pain, sleep disturbances, fatigue and cognitive dysfunctions. However, it is still difficult to apply validated diagnostic criteria. The aim of this study is to examine the accuracy of a previous diagnosis/diagnostic hypothesis of FM according to the 2016 ACR diagnostic criteria. METHODS: All of the patients newly referred to a private rheumatological clinic with the specific request for a consultation because if FM over an 18-month period were evaluated by means of a standardised protocol in order to determine whether they fulfilled the 2016 ACR diagnostic criteria for FM. They were initially divided into three groups: those with a previous diagnosis of FM (group 1), those with a physician's diagnostic hypothesis of FM (group 2) and those who personally hypothesised FM (group 3). They were subsequently classified as having FM, IFM (borderline scores) or not having FM (non-FM) on the basis of the 2016 ACR diagnostic criteria. RESULTS: The study involved 216 patients (25 males and 191 females): 112 in group 1, 49 in group 2, and 55 in group 3. Only 89 patients (41.2%) fulfilled the ACR criteria; 42 (19.44%) met the study protocol-defined scores for IFM; and 85 (39.35%) were diagnosed as not having FM. Only 50% of the patients with a previous diagnosis of FM fulfilled the ACR criteria, and just under 25% did not have FM. Almost 50% of the patients with a physician's diagnostic hypotheses of FM did not have FM, whereas 20% of the patients who personally hypothesised FM fulfilled the ACR criteria. GP scores and TPCs were significantly different (FM > IFM, FM > non-FM, and IFM > non-FM) as were WPI, SSS and PSD scores for FM > IFM group. Rheumatologists made the previous diagnosis in 92.85% of patients, 53.84% of whom met the ACR criteria and about 20% did not have FM; and as many as 37.5% of the patients with a previous diagnosis made by a non-rheumatologist did not have FM. The non-FM patients were given 84 alternative diagnoses, 78.5% of which referred to rheumatic diseases. One hundred and thirty-one patients had 86 closely pain-related co-morbidities, 94.1% of which were rheumatic diseases. CONCLUSIONS: Our findings confirm the inaccuracy of FM diagnoses and highlights the possibility that in everyday clinical practice, they are not always made with reference to very specific criteria and that there is a high risk of classifying non-FM patients as having FM. They also underline the importance of an accurate differential diagnosis. Separately classifying as IFM those patients who do not meet the ACR criteria, but have clinical findings indicating FM, may help to prevent their exclusion from specific treatment(s).
Assuntos
Dor Crônica , Fibromialgia , Doenças Reumáticas , Masculino , Feminino , Humanos , Fibromialgia/psicologia , Inquéritos e Questionários , Medição da Dor/efeitos adversos , Medição da Dor/métodos , Dor Crônica/diagnóstico , Dor Crônica/etiologia , Doenças Reumáticas/complicações , Doenças Reumáticas/diagnóstico , Encaminhamento e ConsultaRESUMO
Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.
Assuntos
Dor Crônica , Fibromialgia , Dor Crônica/diagnóstico , Dor Crônica/etiologia , Dor Crônica/terapia , Fibromialgia/diagnóstico , Fibromialgia/terapia , Humanos , Resultado do TratamentoRESUMO
Early diagnosis and timely and appropriate treatments positively influence the history of fibromyalgia syndrome (FM), with favourable repercussions at clinical, psychological, social and economic levels. Notwithstanding, there are still significant problems with timeliness of diagnosis, access to pharmacological therapies - particularly to innovative ones - and appropriate and effective taking in charge of patients. All the aforementioned factors have a great impact on FM patients' quality of life. Indeed, even though the World Health Organisation recognised FM as a chronic condition in the International Classification of Diseases 10th edition (ICD-10), many countries still fail to recognise the syndrome, and this negatively influences the capability to appropriately protect and care for patients. This is the case in several European Countries. In Italy, a few Regions have started to put in place precise indications for people suffering from FM, aiming at the implementation of diagnostic-therapeutic pathways. The Diagnostic-Therapeutic Care Pathway (DTCP) provides an important tool to meet the needs of patients suffering from chronic diseases. They present the organisation of an integrated assistance network. This includes a seamless path for disease prevention, diagnosis and treatment, by means of cooperation among physicians and other healthcare professionals.
Assuntos
Fibromialgia , Doença Crônica , Europa (Continente) , Fibromialgia/diagnóstico , Fibromialgia/terapia , Humanos , Itália , Qualidade de VidaRESUMO
Fibromyalgia (FM) is currently classified as a chronic pain syndrome. Its main features are chronic widespread pain in the presence of tender points (TPs) upon physical examination, sleep disturbances and fatigue, although patients also report a variety of other complaints. Many therapies have been proposed over recent years with mixed results, including various pharmacological therapies for the treatment of symptoms; but there is still no effective drug treatment for the syndrome itself. Non-pharmacological therapies are an important part of the treatment, and there is evidence supporting a number of interventions, including aerobic exercise, strength and stretching training, cognitive-behavioural therapy, and patient education. Complementary and alternative medicine (CAM) techniques have not yet been fully acknowledged by scientific medicine because little is known about their mechanisms of action and usefulness. The aim of this wide-ranging review of the literature is to analyse the types of CAM techniques used to treat FM and their effectiveness, highlighting the disagreements among the authors of more specialised reviews.
Assuntos
Terapias Complementares , Fibromialgia/terapia , Medicina Baseada em Evidências , Fibromialgia/diagnóstico , Fibromialgia/fisiopatologia , Fibromialgia/psicologia , Humanos , Resultado do TratamentoRESUMO
Reflex sympathetic dystrophy or Complex Regional Pain Syndrome type I (CRPS I) is a painful regional disease with non-metameric topography, which shows extreme pathomorphological variability, from forms in which pain is the only clinical manifestation, to "pseudo-purulent" forms characterized by impressive local manifestations. The use of high doses of bisphosphonates in the treatment of CRPS I is confirmed in different publications which associate their efficacy with their specific biological properties and multiple actions at local level. This case report describes a case of CRPS I in the astragalus of a patient with psoriatic arthritis, successfully treated with intramuscular clodronate.